Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
July 2014—Biocare Medical expanded its automated instrumentation offering with the Oncore Automated Slide Staining System. The Oncore is a compact benchtop instrument that performs both immunohistochemistry and in situ hybridization tests on formalin-fixed, paraffin-embedded tissues.
July 2014—Wako Life Sciences’ µTasWako i30 is available for the serum biomarkers lectin-reactive alpha-fetoprotein (AFP-L3) and des-gamma-carboxy prothrombin (DCP) tests, which are intended for in vitro diagnostic use to help in the risk assessment of patients with chronic liver disease for development of hepatocellular carcinoma in conjunction with other laboratory findings, imaging studies, and clinical assessment.
June 2014—Streck introduced UA-Cellular Complete, a urinalysis control with both chemistry analytes and cellular components to more closely mimic a patient sample.
June 2014—Chembio will begin marketing and selling the FDA-approved and CLIA-waived Chembio HIV 1/2 STAT-PAK assay in the U.S. market.
June 2014—Beckman Coulter entered into an agreement to acquire Xitogen Technologies together with Cytojene Corp. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with an operational base in the China market, and the facilities in Suzhou and Dalian will function as research and development and manufacturing centers.
June 2014—The Poly stat Flu A & B kit from Polymedco is an in vitro, rapid qualitative test that detects influenza type A and B, including numerous strains of H1N1, directly from a nasal or nasopharyngeal swab, as well as nasopharyngeal aspirate/wash specimens.
June 2014—Research presented at the annual conference of the American Society of Breast Surgeons in May reported that molecular subtyping using Agendia’s MammaPrint and BluePrint tests can provide guidance about whether to propose neoadjuvant treatment and what kind of treatment to recommend.
June 2014—AccuCore released AccuPathology 5.0, which includes enhancements in direct support of CoPath, PowerPath, Millennium, and AP Easy LIS. The Lab Equipment module now has optional wireless wi-fi logging to eliminate manual recording of temperatures and humidity levels and includes alerts.
June 2014—HTG Molecular Diagnostics and OvaGene Oncology entered a manufacturing supply agreement in which OvaGene will design and develop its proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.
June 2014—Arlington Scientific received FDA Center for Biologics Evaluation and Research clearance for the ASiManager-AT in rapid plasma reagin (RPR) interpretation and screening of blood donors.
